CAR-T: trailblazing the path from clinical development to the clinic.

Gene Ther

Novartis Oncology, One Health Plaza, East Hanover, NJ, 07936-1080, USA.

Published: June 2018

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41434-018-0013-zDOI Listing

Publication Analysis

Top Keywords

car-t trailblazing
4
trailblazing path
4
path clinical
4
clinical development
4
development clinic
4
car-t
1
path
1
clinical
1
development
1
clinic
1

Similar Publications

-mediated regulation of exhausted CD8 T-cell responses and potential implications for chimeric antigen receptor-T therapy.

Immunotherapy

March 2024

Liver Transplant Center, Department of General Surgery, Huashan Hospital, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China.

Chimeric antigen receptor (CAR) T-cell therapy for malignant tumors has reached a crucial stage, with recent studies underscoring the role of T-cell exhaustion in determining the efficacy of CAR-T therapy. This trailblazing discovery has opened new avenues to augment the potency of CAR-T therapy. Basic leucine zipper ATF-like transcription factor () is indispensable in alleviating T-cell exhaustion and is pivotal in the early stages of CD8 T-cell differentiation.

View Article and Find Full Text PDF

CAR-T: trailblazing the path from clinical development to the clinic.

Gene Ther

June 2018

Novartis Oncology, One Health Plaza, East Hanover, NJ, 07936-1080, USA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!